Zerona is the first non-invasive, non-surgical, aesthetic laser device to receive FDA market clearance in the U.S. for reduction of inches from the waist, hips and thighs. This approval comes following a study conducted to determine the effectiveness of the Zerona laser technology. The findings of the study indicated that patients had an average loss of 3.65 inches combined from the waist, hips and thighs.
Read more on our website about Zerona.
Read the full press release from Erchonia Corporation here.
Zerona has recently been featured in many national news venues:
Good Morning America
Today
The Early Show
The Wall Street Journal
Comments